Cargando…
Genetic Characterization of Brain Metastases in the Era of Targeted Therapy
In the current era of molecularly targeted therapies and precision medicine, choice of cancer treatment has been increasingly tailored according to the molecular or genomic characterization of the cancer the individual has. Previously, the clinical observation of inadequate control of brain metastas...
Autores principales: | Han, Catherine H., Brastianos, Priscilla K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622141/ https://www.ncbi.nlm.nih.gov/pubmed/28993799 http://dx.doi.org/10.3389/fonc.2017.00230 |
Ejemplares similares
-
Targeting Molecular Pathways in Intracranial Metastatic Disease
por: Venur, Vyshak Alva, et al.
Publicado: (2019) -
Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States
por: Smyth, Emily Nash, et al.
Publicado: (2023) -
Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
por: Steindl, Ariane, et al.
Publicado: (2021) -
Editorial: It takes a village: The expanding multi-disciplinary approach to brain metastasis
por: Fecci, Peter E., et al.
Publicado: (2022) -
Brain metastases: lessons and challenges in the targeted therapy and immunotherapy era
por: Lau, Peter Kar Han
Publicado: (2020)